Status:
COMPLETED
Treatment for Anxiety in Children
Lead Sponsor:
National Institute of Mental Health (NIMH)
Conditions:
Obsessive-Compulsive Disorder
Anxiety Disorders
Eligibility:
All Genders
6-17 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to see if it is effective to treat children with anxiety disorders with fluvoxamine. Fluvoxamine has been successfully used to treat obsessive-compulsive disorder (OCD) i...
Detailed Description
To evaluate fluvoxamine in the treatment of children and adolescents with anxiety disorders. Fluvoxamine is a serotonin reuptake inhibitor that is FDA-approved for the treatment of obsessive-compulsi...
Eligibility Criteria
- Patients must have: DSM -IV diagnosis of generalized anxiety disorder, social phobia, or separation anxiety.
Key Trial Info
Start Date :
October 1 1996
Trial Type :
INTERVENTIONAL
End Date :
November 1 1999
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000389
Start Date
October 1 1996
End Date
November 1 1999
Last Update
June 14 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.